Activation pattern of signal transducers and activators of transcription (STAT) factors in inflammatory bowel diseases - PubMed (original) (raw)
Activation pattern of signal transducers and activators of transcription (STAT) factors in inflammatory bowel diseases
Jonas Mudter et al. Am J Gastroenterol. 2005 Jan.
Abstract
Objectives: Cytokine signaling pathways involving transcription factors of the signal transducers and activators of transcription (STAT) family play a key role in the pathogenesis of inflammatory bowel diseases (IBD). STAT proteins are latent cytoplasmic transcription factors that induce transcription upon phosphorylation, dimerization, and nuclear translocation. However, their activation pattern in IBD is poorly understood. The aim of our study was to characterize STAT-expression in IBD.
Methods: Mononuclear cells were isolated from 36 colonic specimens of Crohn's disease, ulcerative colitis, or from control patients. Cells were stimulated overnight with antibodies against human CD2 and CD28 and mononuclear cells were analyzed by flow cytometry. Alternatively, CD4(+) T cells were immunomagnetically separated and then assessed by flow cytometry. Intracellular stainings of the following transcription factors were performed: STAT-1, STAT-2, STAT-3, STAT-4, and STAT-6. In addition, immunofluorescence staining on cryosections for phosphorylated STAT-1 and STAT-3 was performed.
Results: Average expression of the IFN-gamma inducible transcription factor STAT-1 was increased in Crohn's disease as compared to patients with ulcerative colitis and control patients. However, levels of phospho-STAT-1 were surprisingly not markedly upregulated in IBD as compared to controls. In contrast, STAT-3 and phospho-STAT-3 levels were significantly increased in IBD patients as compared to controls (p < 0.01). No differences could be detected in STAT-6 levels. Finally, average expression of STAT-2, which is involved in type I interferon signalling, was downregulated in IBD as compared to control patients.
Conclusions: The analysis of STAT activation patterns could serve as a helpful tool to characterize intestinal inflammation. Furthermore, the IL-6/STAT-3 rather than the IFN-gamma/STAT-1 signaling pathway emerges as a key target for the development of future therapeutic concepts in IBD.
Comment in
- A STAT need for human immunologic studies to understand inflammatory bowel disease.
Plevy S. Plevy S. Am J Gastroenterol. 2005 Jan;100(1):73-4. doi: 10.1111/j.1572-0241.2005.41382.x. Am J Gastroenterol. 2005. PMID: 15654783
Similar articles
- JAK/STAT pathways are not involved in the direct activation of antigen-presenting cells by contact sensitizers.
Valk E, Zahn S, Knop J, Becker D. Valk E, et al. Arch Dermatol Res. 2002 Jul;294(4):163-7. doi: 10.1007/s00403-002-0309-z. Epub 2002 Jun 1. Arch Dermatol Res. 2002. PMID: 12111345 - Activation of STAT proteins and growth control.
Bromberg JF. Bromberg JF. Bioessays. 2001 Feb;23(2):161-9. doi: 10.1002/1521-1878(200102)23:2<161::AID-BIES1023>3.0.CO;2-0. Bioessays. 2001. PMID: 11169589 Review. - Peptide YY attenuates STAT1 and STAT3 activation induced by TNF-alpha in acinar cell line AR42J.
Robinson K, Vona-Davis L, Riggs D, Jackson B, McFadden D. Robinson K, et al. J Am Coll Surg. 2006 May;202(5):788-96. doi: 10.1016/j.jamcollsurg.2006.01.007. J Am Coll Surg. 2006. PMID: 16648019 - CD2 mediates activation of the IFN-gamma intronic STAT binding region in mucosal T cells.
Gonsky R, Deem RL, Young HA, Targan SR. Gonsky R, et al. Eur J Immunol. 2003 May;33(5):1152-62. doi: 10.1002/eji.200322875. Eur J Immunol. 2003. PMID: 12731040 - [STAT pathway of the intracellular signaling].
Nikol'skiĭ NN, Vasilenko KP. Nikol'skiĭ NN, et al. Zh Evol Biokhim Fiziol. 2000 Nov-Dec;36(6):504-8. Zh Evol Biokhim Fiziol. 2000. PMID: 11212528 Review. Russian. No abstract available.
Cited by
- Activation of signal transducer and activator of transcription-1 (STAT-1) and differential expression of interferon-gamma and anti-inflammatory proteins in pelvic ileal pouches for ulcerative colitis and familial adenomatous polyposis.
Leal RF, Ayrizono ML, Milanski M, Coope A, Fagundes JJ, Velloso LA, Coy CS. Leal RF, et al. Clin Exp Immunol. 2010 Jun;160(3):380-5. doi: 10.1111/j.1365-2249.2009.04088.x. Epub 2010 Mar 16. Clin Exp Immunol. 2010. PMID: 20345984 Free PMC article. - Deficiency in STAT1 Signaling Predisposes Gut Inflammation and Prompts Colorectal Cancer Development.
Leon-Cabrera S, Vázquez-Sandoval A, Molina-Guzman E, Delgado-Ramirez Y, Delgado-Buenrostro NL, Callejas BE, Chirino YI, Pérez-Plasencia C, Rodríguez-Sosa M, Olguín JE, Salinas C, Satoskar AR, Terrazas LI. Leon-Cabrera S, et al. Cancers (Basel). 2018 Sep 19;10(9):341. doi: 10.3390/cancers10090341. Cancers (Basel). 2018. PMID: 30235866 Free PMC article. - Altered STAT4 Isoform Expression in Patients with Inflammatory Bowel Disease.
Jabeen R, Miller L, Yao W, Gupta S, Steiner S, Kaplan MH. Jabeen R, et al. Inflamm Bowel Dis. 2015 Oct;21(10):2383-92. doi: 10.1097/MIB.0000000000000495. Inflamm Bowel Dis. 2015. PMID: 26177303 Free PMC article. - Differential regulation of JAK/STAT-signaling in patients with ulcerative colitis and Crohn's disease.
Cordes F, Foell D, Ding JN, Varga G, Bettenworth D. Cordes F, et al. World J Gastroenterol. 2020 Jul 28;26(28):4055-4075. doi: 10.3748/wjg.v26.i28.4055. World J Gastroenterol. 2020. PMID: 32821070 Free PMC article. Review. - Regulation of human intestinal T-cell responses by type 1 interferon-STAT1 signaling is disrupted in inflammatory bowel disease.
Giles EM, Sanders TJ, McCarthy NE, Lung J, Pathak M, MacDonald TT, Lindsay JO, Stagg AJ. Giles EM, et al. Mucosal Immunol. 2017 Jan;10(1):184-193. doi: 10.1038/mi.2016.44. Epub 2016 May 25. Mucosal Immunol. 2017. PMID: 27220814
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous